Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malcolm MacCoss

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
Bioorganic & Medicinal Chemistry Letters|July 28, 2006
4-Amino-2-alkyl-butyramides as small molecule CCR2 antagonists with favorable pharmacokinetic propertiesGabor Butora, Gregori J Morriello, Shankaran Kothandaraman, et al.
Bioorganic & Medicinal Chemistry Letters|November 10, 2006
Alpha-aminothiazole-gamma-aminobutanoic amides as potent, small molecule CCR2 receptor antagonistsChangyou Zhou, Liangqin Guo, William H Parsons, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2006
Highly constrained bicyclic VLA-4 antagonistsLinda L Chang, Quang Truong, George A Doss, et al.
Antimicrobial Agents and Chemotherapy|December 1, 2010
Sustained viral response in a hepatitis C virus-infected chimpanzee via a combination of direct-acting antiviral agentsDavid B Olsen, Mary-Ellen Davies, Larry Handt, et al.
Journal of Medicinal Chemistry|April 28, 2007
Discovery of 3-piperidinyl-1-cyclopentanecarboxamide as a novel scaffold for highly potent CC chemokine receptor 2 antagonistsLihu Yang, Gabor Butora, Richard X Jiao, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2004
Evaluation of pyrrolidin-2-imines and 1,3-thiazolidin-2-imines as inhibitors of nitric oxide synthaseK Shankaran, Karla L Donnelly, Shrenik K Shah, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 2002
Specific and dual antagonists of alpha(4)beta(1) and alpha(4)beta(7) integrinsLinus S Lin, Thomas Lanza, Ermenegilda McCauley, et al.
Journal of Medicinal Chemistry|May 26, 2006
Synthesis and study of alendronate derivatives as potential prodrugs of alendronate sodium for the treatment of low bone density and osteoporosisPetr Vachal, Jeffrey J Hale, Zhe Lu, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 2002
The discovery of small molecule carbamates as potent dual alpha(4)beta(1)/alpha(4)beta(7) integrin antagonistsLinda L Chang, Quang Truong, Richard A Mumford, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2006
Cyclopentane-based human NK1 antagonists. Part 1: discovery and initial SARPaul E Finke, Laura C Meurer, Dorothy A Levorse, et al.
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry Letters|July 28, 2006
4-Amino-2-alkyl-butyramides as small molecule CCR2 antagonists with favorable pharmacokinetic propertiesGabor Butora, Gregori J Morriello, Shankaran Kothandaraman, et al.
Bioorganic & Medicinal Chemistry Letters|November 10, 2006
Alpha-aminothiazole-gamma-aminobutanoic amides as potent, small molecule CCR2 receptor antagonistsChangyou Zhou, Liangqin Guo, William H Parsons, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2006
Highly constrained bicyclic VLA-4 antagonistsLinda L Chang, Quang Truong, George A Doss, et al.
Antimicrobial Agents and Chemotherapy|December 1, 2010
Sustained viral response in a hepatitis C virus-infected chimpanzee via a combination of direct-acting antiviral agentsDavid B Olsen, Mary-Ellen Davies, Larry Handt, et al.
Journal of Medicinal Chemistry|April 28, 2007
Discovery of 3-piperidinyl-1-cyclopentanecarboxamide as a novel scaffold for highly potent CC chemokine receptor 2 antagonistsLihu Yang, Gabor Butora, Richard X Jiao, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2004
Evaluation of pyrrolidin-2-imines and 1,3-thiazolidin-2-imines as inhibitors of nitric oxide synthaseK Shankaran, Karla L Donnelly, Shrenik K Shah, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 2002
Specific and dual antagonists of alpha(4)beta(1) and alpha(4)beta(7) integrinsLinus S Lin, Thomas Lanza, Ermenegilda McCauley, et al.
Journal of Medicinal Chemistry|May 26, 2006
Synthesis and study of alendronate derivatives as potential prodrugs of alendronate sodium for the treatment of low bone density and osteoporosisPetr Vachal, Jeffrey J Hale, Zhe Lu, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 2002
The discovery of small molecule carbamates as potent dual alpha(4)beta(1)/alpha(4)beta(7) integrin antagonistsLinda L Chang, Quang Truong, Richard A Mumford, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2006
Cyclopentane-based human NK1 antagonists. Part 1: discovery and initial SARPaul E Finke, Laura C Meurer, Dorothy A Levorse, et al.
Pageof 7